Güller R
Schweiz Med Wochenschr. 1977 Jun 11;107(23):807-10.
The 12 liquid antacids most frequently used in Switzerland underwent in vitro determination of their buffering capacity, which was then related to their price. There was a twentyfold difference in buffering capacity between the most potent and the weakest antacid, and a 36-fold difference in price between the most expensive and the cheapest preparation. Based on these results and on the literature the guiding principles and effectiveness of antacid therapy in medical practice are discussed.
对瑞士最常使用的12种液体抗酸剂进行了体外缓冲能力测定，并将其与价格相关联。最强效和最弱效抗酸剂之间的缓冲能力相差20倍，最昂贵和最便宜制剂之间的价格相差36倍。基于这些结果并结合文献，讨论了抗酸剂治疗在医学实践中的指导原则和有效性。
